Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
Clinical trial NCT02650752 · COMPLETED
Trial details
- NCT number
- NCT02650752
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2021-01-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.